A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1998
10/20/1998	US5824673 Pharmaceutical compositions comprising metal complexes
10/20/1998	US5824661 Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
10/20/1998	US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998	US5824500 Nucleic acid encoding novel human KDEL receptor
10/20/1998	US5824492 Polypeptides having kinase activity, their preparation and use
10/20/1998	CA2049729C Methods and compositions containing vitamin d compounds for improvement of skin conditions
10/15/1998	WO1998045427A2 Insulin-like growth factor agonist peptides
10/15/1998	WO1998045322A2 Diagnosis method and reagents
10/15/1998	WO1998045297A1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES__
10/15/1998	WO1998045292A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties
10/15/1998	WO1998045291A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
10/15/1998	WO1998045285A1 Somatostatin agonists
10/15/1998	WO1998045268A1 Nicotinamide derivatives
10/15/1998	WO1998045255A1 Calcilytic compounds
10/15/1998	WO1998045250A1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate
10/15/1998	WO1998045242A1 Retinoid activity regulators
10/15/1998	WO1998045230A1 Chromatographic enantiomer separation of lactones
10/15/1998	WO1998044922A1 Somatostatin agonists
10/15/1998	WO1998044921A1 Somatostatin agonists
10/15/1998	WO1998044918A1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
10/15/1998	DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998	DE19714343A1 Chromatographische Enantiomerentrennung von Lactonen Chromatographic separation of the enantiomers of lactones
10/15/1998	CA2287293A1 Somatostatin agonists
10/15/1998	CA2287084A1 Diagnosis method and reagents
10/15/1998	CA2286454A1 Calcilytic compounds
10/15/1998	CA2286264A1 Insulin-like growth factor agonist peptides
10/15/1998	CA2285604A1 Somatostatin agonists
10/15/1998	CA2285223A1 Somatostatin agonists
10/14/1998	EP0870768A1 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
10/14/1998	EP0870036A1 SYNTHETIC MAMMALIAN $g(a)-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME
10/14/1998	EP0870026A1 Ob protein derivatives having prolonged half-life
10/14/1998	EP0870019A2 Cell activation process and reagents therefor
10/14/1998	EP0869974A1 Compounds with growth hormone releasing properties
10/14/1998	EP0869972A1 Chemokine from niddm pancreas
10/14/1998	EP0869954A1 Novel heterocyclic compounds
10/14/1998	EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis
10/14/1998	EP0869942A1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
10/14/1998	EP0869815A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells
10/14/1998	EP0869785A1 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
10/14/1998	EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998	EP0869777A1 Novel method
10/14/1998	EP0869775A1 Dietary fiber delivery system
10/14/1998	EP0630248B1 Use of estriol for the manufacture of a transdermal therapeutic system for treating climacteric osteoporosis
10/14/1998	CN1196087A Novel protein HMW human MP52
10/14/1998	CN1195992A Method and composition for enhanced parenteral nutrition
10/14/1998	CN1195986A Paroxetine controlled release compositions
10/14/1998	CN1195664A New benzoxazinedione derivatives, method of producing them and use thereof
10/14/1998	CN1195531A Drug for curing diabetes and its preparing method
10/14/1998	CN1040210C Fused benzazepine derivative and pharmaceutical composition containing the same
10/14/1998	CA2235057A1 A cosmetic and pharmaceutical formulation containing an andiroba extract
10/13/1998	US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998	US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles
10/13/1998	US5821267 Modulating the inducible isoform over the constitutive; hypertensive, antiarthritic and diabetic agents; therapy with cytokines; toxic and septic shock
10/13/1998	US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion
10/13/1998	US5821253 Tetrahydrobenzo a!fluorene compounds and methods of use
10/13/1998	US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998	US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide
10/13/1998	US5821123 Modified antibody variable domains
10/08/1998	WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998	WO1998043997A1 Novel polypeptide having water channel activity and dna sequence
10/08/1998	WO1998043948A1 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
10/08/1998	WO1998043945A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
10/08/1998	WO1998043652A1 Boron carbohydrate complexes and uses thereof
10/08/1998	WO1998043631A1 Mixture of primary fatty acids obtained from sugar cane wax
10/08/1998	WO1998043624A1 Diabetes remedies
10/08/1998	WO1998043484A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
10/08/1998	WO1998020124A3 Diabetes-mediating proteins and therapeutic uses thereof
10/08/1998	WO1998018429A3 A method for lowering plasma levels of lipoprotein(a)
10/08/1998	DE19722317C1 New human ryanodin receptor type 3 polypeptide
10/08/1998	CA2285452A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
10/08/1998	CA2285360A1 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
10/08/1998	CA2285316A1 Therapeutic agent for diabetes mellitus
10/08/1998	CA2283834A1 Glucagon-like peptide-1 analogs
10/08/1998	CA2283799A1 Novel human serine carboxypeptidase
10/07/1998	EP0869135A1 Glucagon-like peptide-1 analogs
10/07/1998	EP0869121A1 Hypolipidemic propanol amine derivates
10/07/1998	EP0869116A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicaments containing them
10/07/1998	EP0868195A2 Control of protein synthesis, and screening method for agents
10/07/1998	EP0868176A1 Aminoguanidine for treating niddm
10/07/1998	EP0868175A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes
10/07/1998	EP0724566B1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
10/07/1998	EP0711271B1 Aminoindanes and related compounds useful as calcium-channel antagonists
10/07/1998	EP0662948B1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
10/07/1998	EP0654042B1 Amylin muteins
10/07/1998	CN1195375A Angiostatin fragments and aggregate angiostatin and methods of use
10/07/1998	CN1195350A Chemical compounds
10/07/1998	CN1195349A Cyclic GMP-specific phosphodiesterase inhibitors
10/07/1998	CN1195340A Inhibitors of farnesyl-protein transferase
10/07/1998	CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/07/1998	CN1195293A Method for treating disbetes
10/07/1998	CN1194986A Anti-obesity proteins
10/07/1998	CN1194983A New 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them
10/07/1998	CN1194979A Hypolipidemic 1,4-benzothiazepine-1, 1-dioxides
10/07/1998	CN1194976A Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament, and medicament comprising them
10/07/1998	CN1040110C New acyclic amidine group-containing diphosphonic acid derivatives, processes for preparation thereof and pharmaceutical compositions containing them
10/06/1998	US5817912 Transgenic mice with disrupted NPY Y1 receptor genes
10/06/1998	US5817789 Bind to cell surface receptors; genetic engineering
10/06/1998	US5817677 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
10/06/1998	US5817652 Hypolipidaemic condensed 1,4-thiazepines
10/06/1998	US5817648 Vitamin D3 analogues having an unsaturated side chain

1 ... 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 ... 1298